(Q72014999)

English

Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study

scientific article published on 01 January 1995

In more languages
default for all languages
No label defined

No description defined

Statements

Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study (English)
Epirubicin and Medroxyprogesterone Acetate versus Estramustine Phosphate in Hormone-Resistant Prostatic Cancer: A Prospective Randomized Study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit